Literature DB >> 16966407

Role of lgtC in resistance of nontypeable Haemophilus influenzae strain R2866 to human serum.

Alice L Erwin1, Simon Allen, Derek K Ho, Paul J Bonthuis, Paul J Bonthius, Justin Jarisch, Kevin L Nelson, David L Tsao, William C T Unrath, Michael E Watson, Bradford W Gibson, Michael A Apicella, Arnold L Smith.   

Abstract

We are investigating a nontypeable Haemophilus influenzae (NTHI) strain, R2866, isolated from a child with meningitis. R2866 is unusually resistant to killing by normal human serum. The serum 50% inhibitory concentration (IC50) for this strain is 18%, approaching that of encapsulated H. influenzae. R3392 is a derivative of R2866 that was found to have increased sensitivity to human serum (IC50, 1.5%). Analysis of tetrameric repeat regions within lipooligosaccharide (LOS) biosynthetic genes in both strains indicated that the glycosyltransferase gene lgtC was out of frame ("off") in most colonies of R3392 but in frame with its start codon ("on") in most colonies of the parent. We sought antigenic and biochemical evidence for modification of the LOS structure. In a whole-cell enzyme-linked immunosorbent assay, strain R3392 displayed reduced binding of the Galalpha1,4Gal-specific monoclonal antibody 4C4. Mass spectrometry analysis of LOS from strain R2866 indicated that the primary oligosaccharide glycoform contained four heptose and four hexose residues, while that of R3392 contained four heptose and three hexose residues. We conclude that the R2866 lgtC gene encodes a galactosyltransferase involved in synthesis of the 4C4 epitope, as in other strains, and that expression of lgtC is associated with the high-level serum resistance that has been observed for this strain. This is the first description of the genetic basis of high-level serum resistance in NTHI, as well as the first description of LOS composition in an NTHI strain for which the complete genome sequence has been determined.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16966407      PMCID: PMC1695526          DOI: 10.1128/IAI.00722-06

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  55 in total

Review 1.  The simple sequence contingency loci of Haemophilus influenzae and Neisseria meningitidis.

Authors:  C D Bayliss; D Field; E R Moxon
Journal:  J Clin Invest       Date:  2001-03       Impact factor: 14.808

2.  Characterization of non-type B Haemophilus influenzae strains isolated from patients with invasive disease. The HI Study Group.

Authors:  M Cerquetti; M L Ciofi degli Atti; G Renna; A E Tozzi; M L Garlaschi; P Mastrantonio
Journal:  J Clin Microbiol       Date:  2000-12       Impact factor: 5.948

3.  The generation of diversity by Haemophilus influenzae.

Authors:  J N Weiser
Journal:  Trends Microbiol       Date:  2000-10       Impact factor: 17.079

4.  Serum resistance in an invasive, nontypeable Haemophilus influenzae strain.

Authors:  B J Williams; G Morlin; N Valentine; A L Smith
Journal:  Infect Immun       Date:  2001-02       Impact factor: 3.441

5.  Haemophilus influenzae type b strain A2 has multiple sialyltransferases involved in lipooligosaccharide sialylation.

Authors:  Paul A Jones; Nicole M Samuels; Nancy J Phillips; Robert S Munson; Joel A Bozue; Julie A Arseneau; Wade A Nichols; Anthony Zaleski; Bradford W Gibson; Michael A Apicella
Journal:  J Biol Chem       Date:  2002-02-12       Impact factor: 5.157

6.  Adaptation of Haemophilus influenzae to acquired and innate humoral immunity based on phase variation of lipopolysaccharide.

Authors:  J N Weiser; N Pan
Journal:  Mol Microbiol       Date:  1998-11       Impact factor: 3.501

7.  Digalactoside expression in the lipopolysaccharide of Haemophilus influenzae and its role in intravascular survival.

Authors:  Ruth Griffin; Chris D Bayliss; Mark A Herbert; Andrew D Cox; Katherine Makepeace; James C Richards; Derek W Hood; E Richard Moxon
Journal:  Infect Immun       Date:  2005-10       Impact factor: 3.441

8.  The structural heterogeneity of the lipooligosaccharide (LOS) expressed by pathogenic non-typeable Haemophilus influenzae strain NTHi 9274.

Authors:  M M Rahman; X X Gu; C M Tsai; V S Kolli; R W Carlson
Journal:  Glycobiology       Date:  1999-12       Impact factor: 4.313

9.  The lbgAB gene cluster of Haemophilus ducreyi encodes a beta-1,4-galactosyltransferase and an alpha-1,6-DD-heptosyltransferase involved in lipooligosaccharide biosynthesis.

Authors:  Michael V Tullius; Nancy J Phillips; N Karoline Scheffler; Nicole M Samuels; Robert S Munson Jr; Eric J Hansen; Marla Stevens-Riley; Anthony A Campagnari; Bradford W Gibson
Journal:  Infect Immun       Date:  2002-06       Impact factor: 3.441

10.  Lipooligosaccharide P(k) (Galalpha1-4Galbeta1-4Glc) epitope of moraxella catarrhalis is a factor in resistance to bactericidal activity mediated by normal human serum.

Authors:  A Zaleski; N K Scheffler; P Densen; F K Lee; A A Campagnari; B W Gibson; M A Apicella
Journal:  Infect Immun       Date:  2000-09       Impact factor: 3.441

View more
  24 in total

1.  Uptake of Sialic Acid by Nontypeable Haemophilus influenzae Increases Complement Resistance through Decreasing IgM-Dependent Complement Activation.

Authors:  Marjolein M P Oerlemans; Sam J Moons; Jurriaan J A Heming; Thomas J Boltje; Marien I de Jonge; Jeroen D Langereis
Journal:  Infect Immun       Date:  2019-05-21       Impact factor: 3.441

2.  LuxS promotes biofilm maturation and persistence of nontypeable haemophilus influenzae in vivo via modulation of lipooligosaccharides on the bacterial surface.

Authors:  Chelsie E Armbruster; Wenzhou Hong; Bing Pang; Kristin E Dew; Richard A Juneau; Matthew S Byrd; Cheraton F Love; Nancy D Kock; W Edward Swords
Journal:  Infect Immun       Date:  2009-06-29       Impact factor: 3.441

3.  Peroxiredoxin-glutaredoxin and catalase promote resistance of nontypeable Haemophilus influenzae 86-028NP to oxidants and survival within neutrophil extracellular traps.

Authors:  Richard A Juneau; Bing Pang; Chelsie E Armbruster; Kyle A Murrah; Antonia C Perez; W Edward Swords
Journal:  Infect Immun       Date:  2014-10-27       Impact factor: 3.441

4.  RbsB (NTHI_0632) mediates quorum signal uptake in nontypeable Haemophilus influenzae strain 86-028NP.

Authors:  Chelsie E Armbruster; Bing Pang; Kyle Murrah; Richard A Juneau; Antonia C Perez; Kristin E D Weimer; W Edward Swords
Journal:  Mol Microbiol       Date:  2011-10-20       Impact factor: 3.501

5.  The modA10 phasevarion of nontypeable Haemophilus influenzae R2866 regulates multiple virulence-associated traits.

Authors:  Timothy M VanWagoner; John M Atack; Kevin L Nelson; Hannah K Smith; Kate L Fox; Michael P Jennings; Terrence L Stull; Arnold L Smith
Journal:  Microb Pathog       Date:  2015-12-21       Impact factor: 3.738

6.  Underlying Glycans Determine the Ability of Sialylated Lipooligosaccharide To Protect Nontypeable Haemophilus influenzae from Serum IgM and Complement.

Authors:  Mary Darby Jackson; Sandy M Wong; Brian J Akerley
Journal:  Infect Immun       Date:  2019-10-18       Impact factor: 3.441

7.  Binding of complement regulators to invasive nontypeable Haemophilus influenzae isolates is not increased compared to nasopharyngeal isolates, but serum resistance is linked to disease severity.

Authors:  Teresia Hallström; Fredrik Resman; Mikael Ristovski; Kristian Riesbeck
Journal:  J Clin Microbiol       Date:  2010-01-20       Impact factor: 5.948

8.  Adhesin genes and serum resistance in Haemophilus influenzae type f isolates.

Authors:  Michael E Watson; Kevin L Nelson; Victoria Nguyen; Carey-Ann D Burnham; Jill E Clarridge; Xuan Qin; Arnold L Smith
Journal:  J Med Microbiol       Date:  2012-12-14       Impact factor: 2.472

9.  Lex2B, a phase-variable glycosyltransferase, adds either a glucose or a galactose to Haemophilus influenzae lipopolysaccharide.

Authors:  M E Deadman; P Hermant; M Engskog; K Makepeace; E R Moxon; E K H Schweda; D W Hood
Journal:  Infect Immun       Date:  2009-03-16       Impact factor: 3.441

10.  Association of IS1016 with the hia adhesin gene and biotypes V and I in invasive nontypeable Haemophilus influenzae.

Authors:  Sarah W Satola; Brooke Napier; Monica M Farley
Journal:  Infect Immun       Date:  2008-09-15       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.